The latest developments in technological innovation, decentralised clinical trials, and patient experience, plus our groundbreaking mdtalk webinar series – delving into the most important issues in clinical research, with some of the industry’s most influential people.
New FDA Guidance Provides Details on Diversity Action Plans for Clinical Studies
Posted | July 9, 2024FDA Guidance Summary The U.S. Food and Drug Administration (FDA) has issued a draft guidance titled “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies.”…
